|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn297175118 |
003 |
OCoLC |
005 |
20231117033224.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
090106s1967 enka ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d N$T
|d OCLCQ
|d IDEBK
|d OCLCQ
|d E7B
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d OCLCA
|d LEAUB
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 646756461
|a 1162102276
|
020 |
|
|
|a 9780080862538
|q (electronic bk.)
|
020 |
|
|
|a 0080862535
|q (electronic bk.)
|
020 |
|
|
|a 0444533249
|q (electronic bk.)
|
020 |
|
|
|a 9780444533241
|q (electronic bk.)
|
020 |
|
|
|a 1281715980
|
020 |
|
|
|a 9781281715982
|
020 |
|
|
|a 9786611715984
|
020 |
|
|
|a 6611715983
|
035 |
|
|
|a (OCoLC)297175118
|z (OCoLC)646756461
|z (OCoLC)1162102276
|
050 |
|
4 |
|a RS403
|b .P76eb vol. 5
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.19
|2 22
|
245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n 5 /
|c edited by G.P. Ellis and G.B. West.
|
246 |
1 |
4 |
|a Progress in medicinal chemistry.
|n Volume 5
|
260 |
|
|
|a London :
|b Butterworths,
|c 1967.
|
300 |
|
|
|a 1 online resource (xi, 391 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Progress in medicinal chemistry ;
|v 5
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Progress in Medicinal Chemistry, Volume 5; Copyright Page; CONTENTS; Preface; CHAPTER 1. POLYPEPTIDE ANTIBIOTICS OF MEDICINAL INTEREST; 1. Introduction; 2. Classification of peptides; 3. Techniques of peptide chemistry; 4. Polypeptide antibiotics produced by B. brevis; 5. Peptide antibiotics pioduced by B. subtilis and B. licheniformis; 6. Polypeptide antibiotics produced by other strains of bacilli; 7. Polypeptide antibiotics produced by streptomyces; 8. Polypeptide antibiotics produced by fungi; 9. Polypeptide antibiotics isolated from different sources
|
505 |
8 |
|
|a 10. Biosynthesis of polypeptide antibiotics11. Mechanism of action of polypeptide antibiotics; CHAPTER 2. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; 1. Introduction; 2. The nature and mechanism of inflammation; 3. Tests for anti-inflammatory activity; 4. Anti-inflammatory compounds; 5. Mode of action; 6. Uncoupling of oxidative phosphorylation; 7. Inhibition of hyaluronidase; 8. Stimulation of the adrenal cortex; 9. Chelation; 10. Hyperglycaemia; 11. Effects on immunological processes; CHAPTER 3. THE PHARMACOLOGY OF HEPARIN AND HEPARINOIDS; 1. Introduction
|
505 |
8 |
|
|a 2. Complexing properties of heparin, heparinoids and mucopolysaccharides3. Biological reactions of heparin and heparinoids; 4. Anticoagulant activity; 5. Haemorrhage and thrombosis; 6. Chemical structure and biological activity; 7. Absorption, distribution and metabolism; 8. Toxicity; 9. Endogenous heparin and heparinoids; CHAPTER 4. THE HISTIDINE DECARBOXYLASES; 1. Introduction; 2. The measurement of histidine decarboxylase activity; 3. The substrate specificity of histidine decarboxylases; 4. The distribution of histidine decarboxylases
|
505 |
8 |
|
|a 5. The mechanism of action of histidine decarboxylases6. Inhibition of histidine decarboxylation in vitro; 7. Inhibition of histidine decarboxylation in vivo; 8. Factors which modify the histidine decarboxylase activity of tissues; 9. The physiological function of histidine decarboxylases; 10. Concluding remarks; CHAPTER 5. PSYCHOT'ROPIC DRUGS AND NEUROHUMORAL SUBSTANCES IN THE CENTRAL NERVOUS SYSTEM; 1. Introduction; 2. The physiological background; 3. Humoral factors in the brain; 4. Classification and properties of the psychotropic drugs; 5. Psychotropic drugs and neurohumoral processes
|
505 |
8 |
|
|a 6. ConclusionsCHAPTER 6. THE NITROFURANS; 1. Introduction to historical development; 2. Chemical and physical properties of nitrofuran compounds; 3. Synthesis of nitrofurans; 4. Toxicology, pharmacology and tolerancv; 5. Assays of nitrofurans; 6. Metabolism of nitrofurans; 7. Antibacterial properties in vitro; 8. Antibacterial properties in vivo; Addendum; Index
|
520 |
|
|
|a PROGRESS IN MEDICINAL CHEMISTRY 5.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
700 |
1 |
|
|a Ellis, G. P.
|q (Gwynn Pennant)
|
700 |
1 |
|
|a West, G. B.
|q (Geoffrey Buckle),
|d 1916-1990.
|
776 |
0 |
8 |
|i Print version:
|t Progress in medicinal chemistry. 5.
|d London : Butterworths, 1967
|z 9780444533241
|w (OCoLC)18802386
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444533241
|z Texto completo
|